Stable formulations of insulinotropic peptides

Details for Australian Patent Application No. 2005303777 (hide)

Owner Novo Nordisk A/S

Inventors Lilleore, Anne-Mette; Nielsen, Bjarne Ronfeldt; Boving, Tine Elisabeth Gottschalk; Ludvigsen, Svend; Bonde, Claude; Engelund, Dorthe Kot; Schlein, Morten

Agent Shelston IP

Pub. Number AU-B-2005303777

PCT Pub. Number WO2006/051110

Priority PA 2004 01906 08.12.04 DK; PCT/ EP2005/055916 11.11.05 EP; 05104172.1 18.05.05 EP; 05104050.9 13.05.05 EP; PA 2004 01753 12.11.04 DK

Filing date 14 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 16 December 2010

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/051110 Priority application(s): WO2006/051110

16 December 2010 Application Accepted

  Published as AU-B-2005303777

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303778-S-mirtazapine for the treatment of hot flush

2005303773-Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer